why hca has so much debt?

HCA's debt story is one of the most interesting capital structure case studies in American corporate history. The debt is not a mistake or a sign of financial distress — it is a deliberate, rational, and sustained strategic choice that has created enormous shareholder wealth. Let me explain why from the ground up.

The Three Origins of HCA's Debt

HCA's ~$45 billion in debt comes from three distinct, overlapping sources that have compounded over time.

Origin 1: The 2006 KKR/Bain LBO — The Original Sin

Everything starts here. In 2006, KKR, Bain Capital, Merrill Lynch and the Frist family took HCA private in a $33 billion leveraged buyout — the largest in history at the time — loading the company with approximately $28 billion in debt. sec

When HCA re-IPO'd in 2011, it did not pay down that LBO debt — it came back to the public markets already deeply leveraged. The PE firms extracted their returns through the IPO and subsequent share sales, but the debt remained on HCA's balance sheet. This is the permanent baseline of HCA's debt load. Every refinancing since has essentially rolled this debt forward at successively lower interest rates, never meaningfully reducing the principal.

This is a critical distinction from, say, CHS — whose debt came from an operationally disastrous acquisition. HCA's foundational debt came from a PE transaction on a healthy business, and the business was strong enough to service it comfortably from day one.

Origin 2: Aggressive Share Buybacks Funded by Debt — The Ongoing Machine

This is the engine that keeps the debt elevated even as the business generates enormous cash flow, and it is entirely intentional.

The logic is a form of financial engineering that works beautifully when executed on a high-quality, stable-cash-flow business:

1. HCA generates ~$7–8 billion in free cash flow per year
2. Rather than using that cash to pay down debt, it borrows more and buys back its own shares
3. Fewer shares outstanding means each remaining share is worth more — EPS grows even if net income is flat
4. The interest rate on HCA's debt (~4–5%) is far cheaper than the implied earnings yield on its stock (~8–10%), making debt-financed buybacks mathematically accretive

The scale of this is staggering. HCA bought back 26.7 million shares in 2025 alone and authorized a new $10 billion repurchase program. In 2022, the company bought back $7 billion or 30 million shares in a single year. Since the 2011 IPO, HCA has bought back well over $40 billion of its own stock — nearly the entire current market cap. This buyback activity is financed partly by cash flow and partly by issuing new debt, keeping total debt elevated even as the business grows. sec

The result of this relentless buyback machine: HCA's total stockholders' equity as of December 2025 was negative $6 billion. The company has literally bought back more than 100% of its book equity. This sounds alarming but is actually a sign of financial confidence — you only run negative equity through buybacks if you are certain the business will generate enough cash flow to service the debt indefinitely. Patch

Origin 3: $5 Billion Per Year in Organic CapEx — Building for Growth

HCA spends approximately $5 billion per year building new hospitals, expanding existing facilities, adding surgery centers, and upgrading technology — all funded with a combination of operating cash flow and debt issuance.

This is not wasteful spending. It is the primary source of HCA's long-term revenue and earnings growth. Every new hospital tower, every new freestanding ER, every new surgery center adds incremental revenue. But because these projects take 3–5 years from groundbreaking to full profitability, there is always a lag between the debt incurred (upfront) and the returns generated (over time). The permanent CapEx cycle means HCA is always carrying the debt from projects not yet at full utilization.

Why This is Smart, Not Reckless

The key to understanding HCA's debt is the difference between leverage level and leverage risk. They are not the same thing.

HCA carries ~$45 billion in debt at approximately 3.0–3.5x EBITDA. This sounds large in absolute terms. But consider the characteristics of the business servicing that debt:

Cash flow is extraordinarily stable. People do not stop having heart attacks, strokes, or accidents in recessions. Hospital volumes are among the least economically sensitive in the entire economy. HCA's free cash flow has grown consistently for over a decade, never going negative even during COVID (when the government provided relief funding). Over the trailing 12 months to mid-2025, free cash flow totaled $7.3 billion, representing 29.3% growth year-over-year. aol

The interest coverage ratio is very comfortable. HCA generates enough operating income to cover its interest expense approximately 5–6x over. Even with $45 billion in debt, the annual interest bill (~$2 billion) is a manageable fraction of ~$14–15 billion in EBITDA.

The debt is long-dated and fixed rate. HCA has been an active bond issuer and refinancer, consistently extending maturities and locking in fixed rates. There is no near-term maturity cliff that could create a liquidity crisis.

The Negative Equity — Why It's a Feature, Not a Bug

HCA's debt-to-equity ratio is negative 8.08x, because its total stockholders' equity of negative $6 billion makes the ratio mathematically nonsensical by conventional metrics. Patch

This negative equity is entirely the result of buying back more stock than the company has generated in retained earnings — not operating losses, not write-downs, not bad acquisitions. It is the mechanical result of returning capital to shareholders faster than earnings accumulate.

The best parallel is Apple. Apple also has negative or near-zero book equity because it has returned trillions to shareholders through buybacks and dividends. No one considers Apple's balance sheet a warning sign — it reflects a business so confident in its earnings power that it has returned all its equity to owners and borrowed against future earnings. HCA is the hospital sector's version of the same philosophy, executed over a longer time period on a more debt-intensive base.

The One Genuine Risk: What Could Go Wrong

The debt is not riskless. The scenario where it becomes dangerous is a sustained, simultaneous hit to volumes and pricing:

• A deep, prolonged recession that reduces elective surgical volumes
• A severe Medicaid/Medicare cut that compresses margins faster than costs can be reduced
• A rise in interest rates that makes refinancing expensive

In any of these scenarios, HCA's high debt amplifies the downside. A company with no debt and the same earnings decline loses earnings; a company with 3x leverage and the same decline loses earnings and faces rising financial costs. This is why HCA's stock is more volatile than its underlying business fundamentals would suggest — the leverage is a return amplifier in both directions.

But management has clearly judged that the probability of a catastrophic, sustained revenue collapse is low enough that maintaining high leverage to fund buybacks and CapEx is the value-maximizing choice for shareholders. Given the track record — decades of consistent cash flow generation, never a near-bankruptcy moment, a stock that has massively outperformed the market over 15 years — it is hard to argue they have been wrong.

The Simple Summary

HCA's debt is not evidence of a company living beyond its means. It is evidence of a management team that has concluded, correctly so far, that a predictable, cash-generative hospital business can carry substantial leverage while still growing earnings per share aggressively — and that deploying every dollar of free cash flow into buybacks and growth CapEx rather than debt repayment is the highest-return use of capital available to them.